GlassScriptPhysician profile
Martha G Cano
NPI 1861651598
$1,914.02
in general payments reported to CMS, 2019-2025
19 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $273 · 2021: $209 · 2022: $236 · 2023: $387 · 2024: $262 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $564.56 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $384.27 | 2019-2025 | Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $130.29 | 2021-2022 | |
| Mylan Specialty L.P. | $104.52 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.87 | 2021-2023 | Xifaxan |
| Abbvie INC. | $97.05 | 2023 | Vraylar |
| Sanofi-Aventis U.S. LLC | $96.43 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.11 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $59.75 | 2019-2024 | Farxiga |
| Exact Sciences Corporation | $46.10 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $42.82 | 2020 | |
| Pfizer INC. | $38.84 | 2019-2020 | |
| Amarin Pharma, INC. | $37.37 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $36.33 | 2024 | Xarelto |
| Amgen INC. | $34.02 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.56 | 2022 | |
| Romark Laboratories, Lc | $24.00 | 2020 | |
| Abbott Laboratories | $20.38 | 2022 | |
| Shire North American Group INC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Cano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.